secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001193125-26-096474
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics raises CFO Jason D. Davis base salary to $400,000
----------------------------------------------------------------

- CFO Jason D. Davis annual base salary increased to $400,000, effective January 1, 2026.
- Target non-equity incentive compensation remains at 40% of base salary.
- No other changes to CFO compensation or role were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526096474/0001193125-26-096474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526096474/fblg-20260304.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-096474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer